Rapid quantification of a cleavable antibody-conjugated drug by liquid chromatography/tandem mass spectrometry with microwave-assisted enzymatic cleavage
- 1 September 2016
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 128, 226-235
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Brentuximab Vedotin (SGN-35)Clinical Cancer Research, 2011
- Expression of the intestinal biomarkers Guanylyl cyclase C and CDX2 in poorly differentiated colorectal carcinomasHuman Pathology, 2010
- Antibody−Drug Conjugates: Linking Cytotoxic Payloads to Monoclonal AntibodiesBioconjugate Chemistry, 2009
- Novel Peptide Linkers for Highly Potent Antibody−Auristatin ConjugateBioconjugate Chemistry, 2008
- Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic indexNature Biotechnology, 2008
- Pharmacokinetics and Biodistribution of the Antitumor Immunoconjugate, Cantuzumab Mertansine (huC242-DM1), and Its Two Components in MiceThe Journal of Pharmacology and Experimental Therapeutics, 2004
- cAC10-vcMMAE, an anti-CD30–monomethyl auristatin E conjugate with potent and selective antitumor activityBlood, 2003
- Monoclonal antibody drug immunoconjugates for targeted treatment of cancerCancer Immunology, Immunotherapy, 2003
- Cathepsin B-sensitive dipeptide prodrugs. 1. A model study of structural requirements for efficient release of doxorubicinBioorganic & Medicinal Chemistry Letters, 1998
- Mice Lacking the Guanylyl Cyclase C Receptor Are Resistant to STa-Induced Intestinal SecretionBiochemical and Biophysical Research Communications, 1997